ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice

References

• Ahn K, Meyer T H, Uebel S, Sempe P, Djaballah H, Yang Y, Peterson P A, Fruh K, Tampe R. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J 1996; 15: 3247–3255, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Arvin A M, Yeager A S, Bruhn F W, Grossman M. Neonatal herpes simplex infection in the absence of mucocutaneous lesions. J Pediatr 1982; 100: 715–721, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bullido M J, Martinez-Garcia A, Artiga M J, Aldudo J, Sastre I, Gil P, Coria F, Muñoz D G, Hachinski V, Frank A, Valdivieso F. A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers. Neurobiol Aging 2006, at press[CSA]
   Google Scholar
• Burgos J S, Guzman-Sanchez F, Sastre I, Fillat C, Valdivieso F. Non-invasive bioluminescence imaging for monitoring herpes simplex virus type 1 hematogenous infection. Microbes Infect 2006a; 8: 1330–1338, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Burgos J S, Ramirez C, Guzman-Sanchez F, Alfaro J M, Sastre I, Valdivieso F. Hematogenous vertical transmission of herpes simplex virus type 1 in mice. J Virol 2006b; 80: 2823–2831, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Burgos J S, Ramirez C, Sastre I, Alfaro J M, Valdivieso F. Herpes simplex virus type 1 infection via the bloodstream with apolipoprotein E dependence in the gonads is influenced by gender. J Virol 2005; 79: 1605–1612, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Burgos J S, Ramirez C, Sastre I, Bullido M J, Valdivieso F. Involvement of apolipoprotein E in the hematogenous route of herpes simplex virus type 1 to the central nervous system. J Virol 2002a; 76: 12394–12398, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Burgos J S, Ramirez C, Sastre I, Bullido M J, Valdivieso F. ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1. Neuroreport 2003; 14: 1825–1827, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Burgos J S, Ramirez C, Tenorio R, Sastre I, Bullido M J. Influence of reagents formulation on real-time PCR parameters. Mol Cell Probes 2002b; 16: 257–260, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Fruh K, Ahn K, Djaballah H, Sempe P, van Endert P M, Tampe R, Peterson P A, Yang Y. A viral inhibitor of peptide transporters for antigen presentation. Nature 1995; 375: 415–418, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gadola S D, Moins-Teisserenc H T, Trowsdale J, Gross W L, Cerundolo V. TAP deficiency syndrome. Clin Exp Immunol 2000; 121: 173–178, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Galocha B, Hill A, Barnett B C, Dolan A, Raimondi A, Cook R F, Brunner J, McGeoch D J, Ploegh H L. The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. J Exp Med 1997; 185: 1565–1572, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Goldsmith K, Chen W, Johnson D C, Hendricks R L. Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response. J Exp Med 1998; 187: 341–348, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995; 375: 411–415, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hill A, Ploegh H. Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigen. Proc Natl Acad Sci U S A 1995; 92: 341–343, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Hill A B, Barnett B C, McMichael A J, McGeoch D J. HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J Immunol 1994; 152: 2736–2741, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Itzhaki R. Herpes simplex virus type 1, apolipoprotein E and Alzheimer' disease. Herpes 2004; 11(Suppl 2)77A–82A, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Jamieson G A, Maitland N J, Wilcock G K, Yates C M, Itzhaki R F. Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. J Pathol 1992; 167: 365–368, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Johnson R T. The pathogenesis of herpes virus encephalitis. I. Virus pathways to the nervous system of suckling mice demonstrated by fluorescent antibody staining. J Exp Med 1964; 119: 343–356, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kern E R, Overall J C, Jr, Glasgow L A. Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine. J Infect Dis 1973; 128: 290–299, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lascano E F, Berria M I. Histological study of the progression of herpes simplex virus in mice. Arch Virol 1980; 64: 67–79, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Lin W R, Shang D, Itzhaki R F. Neurotropic viruses and Alzheimer disease. Interaction of herpes simplex type 1 virus and apolipoprotein E in the etiology of the disease. Mol Chem Neuropathol 1996; 28: 135–141, [INFOTRIEVE], [CSA]
   Google Scholar
• Mavromara-Nazos P, Ackermann M, Roizman B. Construction and properties of a viable herpes simplex virus 1 recombinant lacking coding sequences of the alpha 47 gene. J Virol 1986; 60: 807–812, [INFOTRIEVE], [CSA]
   Google Scholar
• Momburg F, Hengel H. Corking the bottleneck: the transporter associated with antigen processing as a target for immune subversion by viruses. Curr Top Microbiol Immunol 2002; 269: 57–74, [INFOTRIEVE], [CSA]
   Google Scholar
• Momburg F, Roelse J, Howard J C, Butcher G W, Hammerling G J, Neefjes J J. Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 1994; 367: 648–651, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Montgomerie J Z, Becroft D M, Croxson M C, Doak P B, North J D. Herpes-simplex-virus infection after renal transplantation. Lancet 1969; 2: 867–871, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Orr M T, Edelmann K H, Vieira J, Corey L, Raulet D H, Wilson C B. Inhibition of MHC class I is a virulence factor in herpes simplex virus infection of mice. PLoS Pathogens 2005; 1: 62–71, [CROSSREF], [CSA]
   Google Scholar
• Rammensee H G, Falk K, Rotzschke O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 1993; 11: 213–244, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Recuero M, Serrano E, Bullido M J, Valdivieso F. Abeta production as consequence of cellular death of a human neuroblastoma overexpressing APP. FEBS Lett 2004; 570: 114–118, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Schumacher T N, Kantesaria D V, Heemels M T, Ashton-Rickardt P G, Shepherd J C, Fruh K, Yang Y, Peterson P A, Tonegawa S, Ploegh H L. Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. J Exp Med 1994; 179: 533–540, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Spies T, Bresnahan M, Bahram S, Arnold D, Blanck G, Mellins E, Pious D, DeMars R. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 1990; 348: 744–747, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Steiner I, Kennedy P G. Herpes simplex virus latent infection in the nervous system. J NeuroVirol 1995; 1: 19–29, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Tomazin R, Hill A B, Jugovic P, York I, van Endert P, Ploegh H L, Andrews D W, Johnson D C. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J 1996; 15: 3256–3266, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979; 76: 4350–4354, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 1989; 7: 601–624, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Van Kaer L, Ashton-Rickardt P G, Ploegh H L, Tonegawa S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell 1992; 71: 1205–1214, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• York I A, Roop C, Andrews D W, Riddell S R, Graham F L, Johnson D C. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 1994; 77: 525–535, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar